nference and BeiGene Collaborate on B-Cell Cancer Research
nference and BeiGene have announced a collaboration to advance research in B-cell cancers, specifically targeting chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). This partnership, announced in a press release, will utilize nference's proprietary Agentic AI platform to analyze real-world data from over 700 patient charts. The goal is to identify treatment patterns and improve clinical practices for these malignancies, which affect lymphocytes, a type of white blood cell crucial to immune function. CLL is noted as the most common adult leukemia in the U.S., highlighting the importance of this research initiative.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
Subscribe to Daily AI Brief
Daily report covering major AI developments and industry news, with both top stories and complete market updates
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read more